You are here

Drug Forecast

A Novel Fluoroquinolone for the Treatment of Acute Bacterial Skin and Skin Structure Infections
The First FDA-Approved Treatment for Tardive Dyskinesia
A New-Generation Lipoglycopeptide for the Treatment Of Acute Bacterial Skin and Skin Structure Infections
A Direct-Acting Oral Anticoagulant Factor Xa Inhibitor
A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis
The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial Infection
A Once-Daily Incretin Mimetic Injection for Type-2 Diabetes
A Monoamine Oxidase B Inhibitor for the Adjunct Treatment of Motor Symptoms in Parkinson’s Disease
An Interleukin-5 Antagonist for Severe Asthma of the Eosinophilic Phenotype
A Mu-Opioid Receptor Agonist for the Treatment Of Irritable Bowel Syndrome With Diarrhea
A Treatment for Hallucinations and Delusions Associated With Parkinson’s Disease
The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women
A Substance P/Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting
A Novel Adjunctive Therapy for Partial-Onset Seizures
A Treatment Option for Chronic Hepatitis C Infection
A Review of Clinical Efficacy and Safety in Epilepsy
An Extended-Release, Long-Acting Injection For the Treatment of Schizophrenia
For the Treatment of Complicated Intra-Abdominal and Urinary Tract Infections
A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder
Newly Approved Treatment Option for Chronic Weight Management in Obese Adults
Once-Daily Combination Therapy for the Maintenance of COPD
A New Inhaled Insulin for the Management Of Type-1 or Type-2 Diabetes Mellitus
A Breakthrough Treatment for Gastric Cancer
A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis
First Recombinant C1 Esterase Inhibitor for the Treatment Of Acute Attacks in Patients With Hereditary Angioedema
A New and Innovative Formulation of An Antipsychotic Treatment for Agitation
A Second-Generation Oxazolidinone to Treat Acute Bacterial Skin and Skin Structure Infections
A Novel Antisense Oligonucleotide Inhibitor for the Management of Homozygous Familial Hypercholesterolemia
A Novel Agent for the Treatment of Actinic Keratoses
A Selective Serotonin 5-HT2C Agonist In the Treatment of Obesity
A Long-Acting Anticholinergic for the Management Of Chronic Obstructive Pulmonary Disease
A Condition of Involuntary Crying or Laughing
Serious Side Effects and a Hefty Price Tag May Limit Its Use
A Novel Agent for Metastatic Castration-Resistant Prostate Cancer
A Breakthrough Therapy for Systemic Lupus Erythematosus
A Novel Phosphodiesterase-4 Inhibitor for the Treatment Of Severe Chronic Obstructive Pulmonary Disease
A Serotonin Partial Agonist and Reuptake Inhibitor For the Treatment of Major Depressive Disorder
The Eighth Angiotensin II Receptor Blocker
A Selective Progesterone Receptor Modulator For Emergency Contraception
A New Approach to Weight Loss in Obese Adults
The First Immunotherapy Agent (Vaccine) For Hormone-Refractory Prostate Cancer